Related Experiment Video
Updated: May 19, 2026

Immunofluorescence Analysis of Endogenous and Exogenous Centromere-kinetochore Proteins
Published on: March 3, 2016
Calcineurin-mediated dephosphorylation stabilizes E2F1 protein by suppressing binding of the FBXW7 ubiquitin ligase
Yuki Sato1, Makoto Habara1, Shunsuke Hanaki1
1Department of Veterinary Biochemistry, Yamaguchi University, Yamaguchi 753-8511, Japan.
Abstract:
The transcription factor E2F1 serves as a regulator of the cell cycle and promotes cell proliferation. It is highly expressed in cancer tissues and contributes to their malignant transformation. Degradation by the ubiquitin-proteasome system may help to prevent such overexpression of E2F1 and thereby to suppress carcinogenesis. A detailed understanding of the mechanisms underlying E2F1 degradation may therefore inform the development of new cancer treatments. We here identified SCFFBXW7 as a ubiquitin ligase for E2F1 by comprehensive analysis. We found that phosphorylation of E2F1 at serine-403 promotes its binding to FBXW7 (F-box/WD repeat-containing protein 7) followed by its ubiquitination and degradation. Furthermore, calcineurin, a Ca2+/calmodulin-dependent serine-threonine phosphatase, was shown to stabilize E2F1 by mediating its dephosphorylation at serine-403 and thereby preventing FBXW7 binding. Treatment of cells with Ca2+ channel blockers resulted in downregulation of both E2F1 protein and the expression of E2F1 target genes, whereas treatment with the Ca2+ ionophore ionomycin induced upregulation of E2F1. Finally, the calcineurin inhibitor FK506 attenuated xenograft tumor growth in mice in association with downregulation of E2F1 in the tumor tissue. Impairment of the balance between the opposing actions of FBXW7 and calcineurin in the regulation of E2F1 abundance may therefore play an important role in carcinogenesis.
Insights
The ubiquitin ligase SCFFBXW7 targets E2F1 for degradation, a process inhibited by calcineurin. This pathway regulates cell proliferation and cancer development, offering potential therapeutic targets.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- E2F1 is a key cell cycle regulator and transcription factor.
- E2F1 overexpression is linked to cancer progression.
- Targeting E2F1 degradation may offer novel cancer therapies.
Purpose of the Study:
- To identify the ubiquitin ligase responsible for E2F1 degradation.
- To elucidate the regulatory mechanisms controlling E2F1 stability.
- To explore the therapeutic potential of modulating E2F1 levels in cancer.
Main Methods:
- Comprehensive analysis to identify SCFFBXW7 as the E2F1 ubiquitin ligase.
- Investigated the role of E2F1 phosphorylation at serine-403 in FBXW7 binding.
- Assessed the impact of calcineurin activity on E2F1 stability.
- Utilized calcium channel blockers, ionomycin, and FK506 in cellular and in vivo models.
Main Results:
- SCFFBXW7 was identified as the ubiquitin ligase for E2F1.
- Phosphorylation of E2F1 at serine-403 promotes its degradation via FBXW7.
- Calcineurin dephosphorylates E2F1 at serine-403, stabilizing the protein.
- Calcium modulation and calcineurin inhibition affect E2F1 levels and target gene expression.
- FK506 treatment inhibited tumor growth in mice by downregulating E2F1.
Conclusions:
- The balance between FBXW7-mediated degradation and calcineurin-mediated stabilization of E2F1 is crucial for cell proliferation and cancer.
- Dysregulation of this balance contributes to carcinogenesis.
- Targeting the FBXW7-calcineurin-E2F1 axis presents a promising therapeutic strategy for cancer treatment.
Related Concept Videos
Negative Regulator Molecules
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
Inhibition of Cdk Activity
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Anaphase Promoting Complex

